Tracon Pharmaceuticals, Inc. 4
4 · Tracon Pharmaceuticals, Inc. · Filed Jun 15, 2017
Insider Transaction Report
Form 4
MATTINGLY MARTIN A
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-06-15+15,000→ 15,000 totalExercise: $2.15Exp: 2027-06-14→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.